Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5475-5478

  Price, John T ^a   Tiganis, Tony ^a   Agarwal, Anurag ^b   Djakiew, Daniel ^b,c   Thompson, Erik W ^a,b,c  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C;

ARTICLE; BREAST CANCER; CELL MIGRATION; CHEMOTAXIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL DIVISION; CELL MOVEMENT; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE C; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033231070     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Radinsky, R., Risin, S., Fan, D., Dong, Z., Bielenberg, D. R., Bucana, C. D., and Fidler, I. J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res., 1: 19-31, 1995.
2. Harris, A. L., Nicholson, S., Sainsbury, R., Wright, C., and Farndon, J. Epidermal growth factor receptor and other oncogenes as prognostic markers. J. Natl. Cancer Inst. Monogr., 181-187, 1992.
3. Price, J. T., Bonovich, M. T., and Kohn, E. C. The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol., 32: 175-253, 1997.
4. Matthay, M. A., Thiery, J. P., Lafont, F., Stampfer, F., and Boyer, B. Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. J. Cell Sci., 106: 869-878, 1993.
5. Xie, H., Pallero, M. A., Gupta, K., Chang, P., Ware, M. F., Witke, W., Kwiatkowski, D. J., Lauffenburger, D. A., Murphy-Ullrich, J. E., and Wells, A. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway. J. Cell Sci., 111: 615-624, 1998.
6. Price, J. T., Wilson, H. M., and Haites, N. E. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer, 32A: 1977-1982, 1996.
7. Turner, T., Chen, P., Goodly, L. J., and Wells, A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis, 14: 409-418, 1996.
8. Davidson, N. E., Gelmann, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptor-positive and -negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987.
9. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P., and Cheresh, D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol., 137: 481-492, 1997.
10. Wennstrom, S., Hawkins, P., Cooke, F., Hara, K., Yonezawa, K., Kasuga, M., Jackson, T., Claesson-Welsh, L., and Stephens, L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol., 4: 385-393, 1994.
11. Chen, P., Xie, H., Sekar, M. C., Gupta, K., and Wells, A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol., 127: 847-857, 1994.
12. Aznavoorian, S., Stracke, M. L., Krutzsch, H., Schiffmann, E., and Liotta, L. A. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J. Cell Biol., 110: 1427-1438, 1990.
13. Ennis, B. W., Lippman, M. E., and Dickson, R. B. The EGF receptor system as a target for antitumor therapy. Cancer Investig., 9; 553-562, 1991.
14. Kato, K., Ueoka, Y., Tamura, T., Nishida, J., and Wake, N. Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas. Eur. J. Cancer, 34: 737-744, 1998.
15. Pukac, L., Huangpu, J., and Karnovsky, M. J. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp. Cell Res., 242: 548-560, 1998.
16. Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., and Zetter, B. R. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature (Lond.), 367: 474-476, 1994.
17. Azuma, T., Witke, W., Stossel, T. P., Hartwig, J. H., and Kwiatkowski, D. J. Gelsolin is a downstream effector of rac for fibroblast motility EMBO J., 17: 1362-1370, 1998.
18. Kundra, V., Anand-Apte, B., Feig, L. A., and Zetter, B. R. The chemotactic response to PDGF-BB: evidence of a role for Ras. J. Cell Biol., 130: 725-731, 1995.
19. Bornfeldt, K. E., Raines, E. W., Nakano, T., Graves, L. M., Krebs, E. G., and Ross, R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Investig., 93: 1266-1274, 1994.
20. Arora, P. D., and McCulloch, C. A. G. Dependence of fibroblast migration on actin severing activity of gelsolin. J. Biol. Chem., 271: 20516-20523, 1996.
21. Scharenberg, A. M., and Kinet, J. P. PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell, 94: 5-8, 1998.
22. Liscia, D. S., Merlo, G., Ciardiello, F., Kim, N., Smith, G. H., Callahan, R., and Salomon, D. S. Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Dev. Biol., 140: 123-131, 1990.